Latest Regulatory Approvals News

Page 197 of 220
Adriatic Metals has announced a two-tranche institutional placement to raise A$80 million, aiming to fast-track the expansion of its Vares Processing Plant and strengthen its balance sheet ahead of commercial production.
Maxwell Dee
Maxwell Dee
18 Feb 2025
SG Fleet Group Limited reported a 9.8% drop in half-year profit to $41.1 million, while announcing a $3.50 per share acquisition scheme by Pacific Equity Partners' vehicle Westmann Bidco.
Claire Turing
Claire Turing
18 Feb 2025
Opthea has completed the final patient visit in its pivotal COAST Phase 3 trial evaluating sozinibercept combined with aflibercept for wet AMD, with topline results expected early Q2 2025.
Ada Torres
Ada Torres
18 Feb 2025
Maximus Resources Limited has issued a Target's Statement recommending shareholders accept Astral Resources NL's off-market takeover bid, which offers a significant premium and improved liquidity. The offer, valuing Maximus shares at approximately $0.073 each, aims to consolidate gold assets in Western Australia under Astral's larger portfolio.
Maxwell Dee
Maxwell Dee
17 Feb 2025
PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.
Ada Torres
Ada Torres
17 Feb 2025
Memphasys has initiated clinical utility testing of its Felix™ System in Brazil through a partnership with Laboratorio Androscience, aiming to establish a foothold in the rapidly growing Latin American IVF sector.
Ada Torres
Ada Torres
17 Feb 2025
E79 Gold Mines has successfully raised $1.8 million through a placement oversubscribed by more than double, aiming to fund exploration at its promising Laverton South Gold Project and bolster working capital.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Recce Pharmaceuticals reports strong Phase II results for its RECCE® 327 topical gel, achieving a 93% efficacy rate in treating serious skin infections and setting the stage for accelerated Phase 3 trials.
Victor Sage
Victor Sage
17 Feb 2025
Prodigy Gold NL has unveiled its comprehensive exploration plans for 2025, targeting resource expansion at Hyperion and Tregony deposits while advancing development options at Old Pirate. The company aims to leverage drilling results and metallurgical studies to accelerate project development in the Northern Territory.
Maxwell Dee
Maxwell Dee
17 Feb 2025
FBR Limited’s exclusive joint venture option with CRH Ventures for its Wall as a Service® offering in the US has expired without exercise, freeing the company to pursue independent financing and partnerships across key American markets.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Larvotto Resources has modified its Hillgrove Antimony-Gold Project to adopt dry stacking for tailings, a move that promises environmental benefits and faster regulatory approval without impacting project economics.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Findi Limited has expanded its ATM footprint with the State Bank of India by 54%, securing 2,293 additional ATMs and appointing Rothschild & Co for its 2026 Indian IPO. However, FY25 revenue guidance has been revised down due to delays in White Label ATM license commencement.
Claire Turing
Claire Turing
17 Feb 2025